Publications by authors named "Greg Ahmann"

Claim this Profile
S
Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progression.
Samaneh Maleknia, Sanam Rezaei Benam, Greg Ahmann, Rafael Fonseca, Diane F Jelinek

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention.
Rodrigo Fonseca, Yuan Xiao Zhu, Laura A Bruins, Joseph Ahmann, Cecilia de Bonolo Campos, Greg Ahmann

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional profiles define drug refractory disease in myeloma.
Yuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, Chang-Xin Shi, Cecilia Bonolo De Campos, Greg J Ahmann

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients.
Mariano Arribas, Greg J Ahmann, Skye Buckner Petty, Esteban Braggio, Elitza S Theel

Am J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity.
Luke Mountjoy, Sinto Sebastian, Tania Jain, Talal Hilal, Miguel Gonzalez-Velez, Greg Ahmann

Leukemia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Direct to Drug" screening as a precision medicine tool in multiple myeloma.
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L Petit, Alysia N Polito, Yuan Xiao Zhu, Greg J Ahmann

Blood Cancer J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC dysregulation in the progression of multiple myeloma.
Kristine Misund, Niamh Keane, Caleb K Stein, Yan W Asmann, Grady Day, Greg Ahmann

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.
Brian S White, Irena Lanc, Julie O'Neal, Harshath Gupta, Robert S Fulton, Greg J Ahmann

Blood Cancer J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma cells' capacity to decompose HO determines lenalidomide sensitivity.
Sinto Sebastian, Yuan X Zhu, Esteban Braggio, Chang-Xin Shi, Sonali C Panchabhai, Greg J Ahmann

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BCL-2/J(H) Translocation in Healthy African Americans.
Gerardo Colon-Otero, Scott A Van Wier, Greg J Ahmann, Esteban Braggio, Monica L Albertie

Ann Hematol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of cereblon expression in multiple myeloma.
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, Greg Ahmann

Leuk Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.
Susanna J Jacobus, Shaji Kumar, Hajime Uno, Scott A Van Wier, Greg J Ahmann

Br J Haematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
Shaji K Kumar, Hajime Uno, Susanna J Jacobus, Scott A Van Wier, Greg J Ahmann

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
Wee J Chng, Shaji Kumar, Scott Vanwier, Greg Ahmann, Tammy Price-Troska

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implication of centrosome amplification in plasma cell neoplasm.
Wee J Chng, Greg J Ahmann, Kim Henderson, Rafael Santana-Davila, Philip R Greipp

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, Philip R Greipp, Mark R Litzow, Greg J Ahmann

Blood· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis